Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Nov-Dec;45(6):449-451.
doi: 10.1097/SGA.0000000000000692. Epub 2022 Sep 6.

SYSTEMIC SARCOIDOSIS-ASSOCIATED HEPATOCELLULAR CARCINOMA: A CASE REPORT

Affiliations
Case Reports

SYSTEMIC SARCOIDOSIS-ASSOCIATED HEPATOCELLULAR CARCINOMA: A CASE REPORT

Derya Arı et al. Gastroenterol Nurs. 2022 Nov-Dec.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

References

    1. Askling J., Grunewald J., Eklund A., Hillerdal G., Ekbom A. (1999). Increased risk for cancer following sarcoidosis. American Journal of Respiratory and Critical Care Medicine, 160, 1668–1672.
    1. Chalasani P., Vohra M., Sheagren J. N. (2005). An association of sarcoidosis with hepatocellular carcinoma. Annals of Oncology, 16, 1714–1715.
    1. Iannuzzi M. C., Rybicki B. A., Teirstein A. S. Sarcoidosis. (2007). New England Journal of Medicine, 357, 2153–2165.
    1. Kronborg I. J., Bhathal P. S., Mackay I. R., Storey E., Long T. M. (1983). Hepatocellular carcinoma in a patient with sarcoidosis-associated chronic active hepatitis and the MZ alpha-1-antitrypsin phenotype. Liver, 3, 92–99.
    1. Kumar A., Dung T. (2016). Hepatocellular carcinoma regression after cessation of immunosuppressive therapy. Journal of Clinical Oncology, 34(10), e90–e92.

Publication types

MeSH terms